Cox Johninsider trades
In SEC Form 4 filings, Cox John is listed as CEO & President of Dyne Therapeutics, Inc. (DYN). In the last 90 days, Cox John sold $106.8K of Dyne Therapeutics, Inc. (DYN) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| DYNDyne Therapeutics, Inc. | CEO & President | 1 | Sep 8 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-08
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.